ResearcherUniversity of IowaNo recent work listed
Matthew S. Alexander
Matched on ORCID iD 0000-0001-6119-6324; OpenAlex author ID A5103092540. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2017: 1 paper · 2018: 4 papers · 2019: 1 paper · 2020: 2 papers
Papers 8
- Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism. First author DOI 10.1038/s41598-020-74806-2↗
- Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer. Co-author DOI 10.1074/jbc.ra120.012798↗
- Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1667/rr15189.1↗
- Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. Co-author DOI 10.1007/s10585-018-9876-z↗
- Treating pancreatic cancer: more antioxidants more problems? Co-author DOI 10.1080/17474124.2018.1494572↗
- Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1680↗
- A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells. Co-author DOI 10.14440/jbm.2018.250↗
- Superoxide Dismutases in Pancreatic Cancer. First author DOI 10.3390/antiox6030066↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joseph J. Cullen · 8 shared papers, 2017–2020 · strength 0.87
- Paper Treating pancreatic cancer: more antioxidants more problems? DOI 10.1080/17474124.2018.1494572↗
- Paper Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism. DOI 10.1038/s41598-020-74806-2↗
- Paper Superoxide Dismutases in Pancreatic Cancer. DOI 10.3390/antiox6030066↗
- Brianne R. O’Leary · 6 shared papers, 2018–2020 · strength 0.58
- Paper Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism. DOI 10.1038/s41598-020-74806-2↗
- Paper Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pan… DOI 10.1074/jbc.ra120.012798↗
- Paper A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells. DOI 10.14440/jbm.2018.250↗
- Juan Du · 6 shared papers, 2018–2020 · strength 0.58
- Paper Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism. DOI 10.1038/s41598-020-74806-2↗
- Paper Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pan… DOI 10.1074/jbc.ra120.012798↗
- Paper A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells. DOI 10.14440/jbm.2018.250↗
- Justin G. Wilkes · 4 shared papers, 2017–2019 · strength 0.35
- Paper Superoxide Dismutases in Pancreatic Cancer. DOI 10.3390/antiox6030066↗
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Garry R. Buettner · 3 shared papers, 2018–2019 · strength 0.24
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Ehab H. Sarsour · 2 shared papers, 2019–2020 · strength 0.21
- Prabhat C. Goswami · 1 shared paper, 2020 · strength 0.11
- Rosa F. Hwang · 1 shared paper, 2019 · strength 0.09
- Zita A. Sibenaller · 1 shared paper, 2018 · strength 0.08
- Susan Tsai · 1 shared paper, 2018 · strength 0.08
- Douglas Robert Spitz · 1 shared paper, 2018 · strength 0.07
- Daniel Berg · 1 shared paper, 2018 · strength 0.07
- John Michael Buatti · 1 shared paper, 2018 · strength 0.07
- Bryan G. Allen · 1 shared paper, 2018 · strength 0.07
- Kellie L. Bodeker · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.